Experimental study of 23, 24-dihydrocucurbitacin B reversing drug resistance of hepatocellular carcinoma by inhibiting Nrf2-ARE pathway
HUANG Liangjiu
ZHONG Jialing
ZHAO Hongmei
WANG Zhengwen
ZHAO Xiaobiao
Machine-generated Keywords：
Publication Date：2020-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 217-223 )